Adial Pharmaceuticals, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol: ADIL on Nasdaq
Industry: Pharmaceutical Preparations
Location: 1180 Seminole Trail, Suite 495, Charlottesville, Virginia

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+700	100%	$2.74	+$1.92K
Sells	0
Net	+1	+700	100%		+$1.92K

Adial Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Cary J. Claiborne	Chief Executive Officer, Director	$639K			Mar 25, 2024
William B. Stilley III	Director	$530K			May 23, 2023
Joseph Truluck	Chief Financial Officer	$111K			Mar 25, 2024
Kevin Schuyler	Director	$2.77K	+$1.92K	+225%	Mar 25, 2024
James W. Newman Jr.	Director				Mar 25, 2024
Kermit J. Anderson	Director				Mar 25, 2024
Robertson H. Gilliland	Director				Mar 25, 2024
Bankole Johnson	Director				May 23, 2023
Tony Goodman	Chief Operating Officer, Director				Mar 25, 2024

Recent Insider Transactions by Companies or Individuals for Adial Pharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.